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Abstract Primary gastric T cell lymphoma is rare and
mostly of large cell type. In this paper, we present a case of
gastric T cell lymphoma morphologically similar to the
gastric marginal zone B cell lymphoma of mucosa-
associated lymphoid tissue (MALT). Morphologically, the
cells are small with abundant clear cytoplasm. Lymphoepi-
thelial lesions are readily identified with diffuse destruction
of gastric glands. Immunohistochemically, the neoplastic
cells are CD3+/CD4+/CD8−/Granzyme B−. Molecular
studies revealed monoclonal T cell receptor γ gene
rearrangement. Clinically, the patient responded initially to
four cycles of R-CHOP, but then progressed. Because
peripheral T cell lymphoma is usually associated with a
poor prognosis, whereas marginal zone B cell lymphoma is
an indolent lymphoproliferative disorder, this morphologic
mimicry should be recognized and completely investigated
when atypical small lymphoid infiltrates with lymphoepi-




Primary gastric lymphomas comprise 4.6% of non-Hodgkin
lymphomas (NHL) and are one of the most common
extranodal NHL (only less common than cutaneous NHL)
[1]. While most of the primary gastric lymphomas are high-
grade B cell lymphomas [2], one low-grade gastric B cell
lymphoma has drawn particular attention in recent years
due to its association with Helicobacter pylori infection [3].
Because this low-grade B cell lymphoma arises from the
mucosa-associated lymphoid tissues (MALT), it was named
by Peter Isaacson as “MALT lymphoma” [4, 5]. It is now
defined by the WHO classification as a distinct pathological
entity “extranodal marginal zone B cell lymphoma of
mucosa-associated lymphoid tissue (MALT lymphoma)”
[6]. MALT lymphoma is characterized by diffuse infiltra-
tion of monocytoid B cells with lymphoid aggregates
invading the gastric glands, forming the so-called lymphoe-
pithelial lesions, which is one of the hallmarks of “MALT
lymphoma” [7]. Although being regarded as a low-grade
malignancy, MALT lymphoma can regress spontaneously
after eradication of H. pylori infection.
In contrast to the commonly occurring primary gastric B
cell lymphomas, primary gastric T cell lymphomas (GTCL)
are extremely rare. In a large study including a population
of 2.8 million subjects over a period of 9 years in Western
Denmark, only six cases of primary GTCL (including three
cases of anaplastic large cell lymphomas) were documented
[8]. Despite the fact that the gastric MALT contains both B
cells and T cells, to our knowledge, a primary GTCL
arising from MALT has never been reported. In this paper,
we present a case of primary GTCL morphologically
mimicking the B cell MALT lymphoma. Therefore, the
differential diagnosis of atypical small lymphoid infiltrates
with lymphoepithelial lesions in the stomach should also
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Report of a case
A 51-year-old African-American male presented with
nausea, vomiting and hematemesis, and profound anemia.
There was no documented history of lymphadenopathy.
Serologic test was negative for human T cell leukemia virus
type 1 (HTLV-1). He had a gastric biopsy 5 months ago,
which was diagnosed in another institution as a “possible T
cell lymphoma versus B cell lymphoma with florid T cell
response.” He was treated with rituxan, cyclophosphamide,
doxorubicin, vincristine, and prednisolone (R-CHOP).
However, his condition declined after the fourth cycle of
R-CHOP. He was transferred to our medical center for
further evaluation.
On admission, a whole-body systemic survey by
positron emission/computed tomography (PET/CT) showed
multiple metabolically active nodular lesions involving the
gastric wall and several perigastric lymph nodes. An
esophagogastroduodenoscopy (EGD) showed many non-
obstructing and nonbleeding cratered gastric ulcers. The
largest lesion measured 3×2 cm and seemed to involve the
muscularis propria. No perforation or bleeding was seen. A
biopsy of this lesion was performed.
Materials and methods
Histology, immunohistochemistry, and in situ hybridization
Two endoscopic gastric biopsy specimens from the antrum,
body, and fundus were initially obtained fresh. One sample
from the gastric body and fundus was available for a
second, follow-up evaluation. The specimens were prepared
for light microscopy by fixing in 10% buffered formalin
and embedding in paraffin. Three-micron tissue sections
were stained with hematoxylin and eosin (H&E). The
immunoperoxidase stains were performed on a Bench-
Mark® XT autostainer (Ventana, Tucson, AZ, USA) using
antibodies against CD3, CD4, CD5, CD8, CD10, CD20,
CD43, CD56, CD79a, cyclin D1, Granzyme B, Ki-67, p53,
pancytokeratin, and H. pylori as primary antibodies
(Ventana). In situ hybridization for Epstein–Barr virus
(EBV) early RNA (EBER) was performed similarly on
the autostainer using a Ventana ISH iVIEW Blue Detection
Kit. Additional paraffin immunoperoxidase stain was
manually performed on paraffin sections using a mouse
antihuman CD103 monoclonal antibody for frozen tissues
(BioLegend, San Diego, CA, USA) with no success.
Flow cytometry
Portions of fresh tissue from the initial biopsy were analyzed
on a BD FacExcalibur (Becton Dickinson, Franklin Lakes,
NJ, USA) using a limited panel of antibodies against CD3,
CD4, CD5, CD8, CD10, CD19, CD20, kappa, and lambda,
conjugated with fluorochromes FITC, PE, Per-CP, and APC
(Becton Dickinson).
Molecular studies
DNA was prepared from 10-μ paraffin sections using a
QIAprep 96 Turbo BioRobot Kit (Qiagene, Valencia, CA,
USA). The TCR genes were PCR-amplified using consensus
V region primers and two J region primers [9]o na
GeneAmp® 9700 PCR amplifier (Perkin Elmer Life And
Analytical Sciences, Waltham, MA, USA). The PCR
products were resolved on a polyacrylamide gel.
Results
Microscopically, the first biopsy showed multiple fragments
of gastric mucosa with dense lymphoid infiltrates composed
of predominately small lymphoid cells with small amount of
clear cytoplasm, round to slightly irregular nuclei, and
clumped chromatin. Lymphoepithelial lesions were readily
identified (Fig. 1a). Some of the gastric glands were almost
entirely destroyed by the lymphoid infiltrates. Because this
morphology is characteristic for MALT lymphoma (Fig. 1b),
our working diagnosis was “extranodal marginal zone B cell
lymphoma of mucosa-associated lymphoid tissue (MALT
lymphoma).”
A limited amount of fresh tissue was submitted for flow
cytometry. With a limited panel of antibodies, the analysis
demonstrated a predominant population of CD3+ T cells
(92% of the total events). Paraffin immunoperoxidase stains
showed that the atypical lymphoid infiltrates were CD3+,
CD4+, CD5+, and CD43+. These cells were negative for
CD8, CD10, CD20, CD56, CD79a, Granzyme B, or cyclin
D1. Stains for CD20 and CD79a highlighted focal residual
reactive small B cells and plasma cells. Stain for CD8
showed only scattered reactive small Tcells. Pancytokeratin
stain revealed the lymphoepithelial lesions commonly
seen in MALT lymphoma (Fig. 2). Immunostain for H.
pylori and in situ hybridization for EBV were negative.
Because frozen tissue was not available, immunostain for
CD103 was manually attempted on the paraffin sections
using a commercially available antibody for frozen tissues
(BioLegend). Our effort failed to stain the CD103+ intra-
epithelial lymphocytes (IEL) in the control intestinal tissues
with various antigen retrieval approaches. Molecular
studies performed on paraffin-embedded tissue identified a
30 J Hematopathol (2008) 1:29–35monoclonal T cell receptor (TCR) γ gene rearrangement
(Fig. 3, lane 2). These findings were consistent with a Tcell
lymphoma with morphologic features of MALT lymphoma
and helper/inducer T cell phenotype.
Intrigued by this morphologic similarity, we compared the
distribution of CD4 (helper/inducer) and CD8 (cytotoxic/
suppressor) T cells in duodenitis, gastritis, and our case. In
duodenitis, while small numbers of CD4+ Tcells were found
to be located predominantly in the interglandular area, the
CD8+ cells, i.e., IEL, were present within the epithelium of
the duodenal glands (data not shown). In contrast, CD4+ T
cells were identified both interglandularly and within the
epithelium, whereas CD8+ cells were present predominantly
within the glandular epithelium in chronic gastritis. In the
current lymphoma case, CD4+ neoplastic cells were pre-
dominantly in the interglandular area of the lamina propria
where the T cell lymphoma might have originated. Con-
versely, CD8+ T cells displayed a similar distribution as in
the chronic gastritis. These findings suggest that the T cell
lymphoma might have arisen from the interglandular CD4+
small T cells seen in chronic gastritis.
Follow-up
Becausethepatient didnot tolerateR-CHOP chemotherapy, he
underwent a local radiation therapy (total 30 Gy in 10
fractions) to the gastric lesions and perigastric lymph nodes.
Two and a half weeks after radiation, a PET/CT scan showed
interval progression even in the radiation field with an increase
in the size of gastrohepatic and retroperitoneal lymph nodes
andceliacnodes.Furthermore,arepeatbiopsyshowedresidual
Fig. 2 Lymphoepithelial lesions of the primary GTCL (antipancyto-
keratin immunoperoxidase stain, ×400 amplification)
a
b
Fig. 1 Morphologic comparison between the current primary GTCL
and a B cell MALT lymphoma (H&E, ×400 amplification). Similar
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Fig. 3 Molecular studies of the primary GTCL before and after the
radiation therapy. DNAs from gastric biopsies before and after
radiotherapy were isolated for PCR amplification using primers for
T cell receptor γ gene. Lane 1 monoclonal control, lane 2 initial
diagnostic biopsy, lane 3 3-month follow-up biopsy, lane 4 polyclonal
control, lane 5 oligoclonal control, lane 6 5% sensitivity monoclonal
control, lane 7 25-bp DNA marker (Invitrogen, Carlsbad, CA, USA)
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(Fig. 4a). No molecular study was performed on this specimen.
The patient was sent home with monthly follow-ups. At
2 months after the radiation therapy, the patient reported
feeling better and gained 20 lbs. About 3 months after the
completion of radiation therapy, a follow-up PET/CT scan
showed resolution of the metabolic activity in the stomach.
However, new pathologic lymphadenopathy was noted in the
chest and abdomen outside of the original radiation ports.
The follow-up gastric biopsy taken at the 3-month mark
showed rare large atypical lymphoid cells in a background of
reactive lymphoplasmacytosis (Fig. 4b). The T cell receptor
γ gene rearrangement study showed oligoclonality (Fig. 3,
lane 3). Among the oligoclonal bands, there was no band
matching the monoclonal band amplified from the original
diagnostic specimen (Fig. 3,l a n e2 ) .
Discussion
We presented a rare case of primary GTCL morphologically
mimicking MALT lymphoma. This case expanded our
knowledge on the differential diagnosis of atypical small
lymphoid infiltrates with lymphoepithelial lesions to in-
clude peripheral T cell lymphoma.
Many cases of primary GTCL had been reported with
the majority of the GTCL being large cell type (Table 1)
[10–19]. Only less than 10 reported GTCL had a small- to
medium-sized cell morphology [12, 19–23]. Some of these
cases occur frequently in HTLV-1 endemic areas and may
represent examples of adult T cell leukemia/lymphoma
(ATLL) [21]. Because gastric lymphomas in patients with
HTLV-1 infection (mostly in Japan) might be better
regarded as involvement by ATLL, those cases were not
included in Table 1. Based on the immunophenotypes of
the reported cases, GTCL can be classified into two major
subtypes: (1) helper/inducer T cell subtype (CD4+/CD8−/
CD103−) and (2) cytotoxic/suppressor Tcell subtype (CD4−/
CD8+ or CD4−/CD8− with expression of CD103 and/or
CD56 (Table 2).
Most of the previously reported primary GTCL was of
the helper/inducer T cell subtype (CD4+/CD8−/CD103−;
Table 1). Due to the lack of fresh tissue and commercially
available anti-CD103 antibody for paraffin immunohisto-
chemistry, we could neither confirm nor exclude the
presence of CD103 in the tumor cells of our patient.
However, according to the previous reports, almost all the
primary CD103+ GTCL were CD4−/CD8+, whereas none
of the CD4+ cases were CD103+ (Table 1). One excep-
tional case of GTCL with a CD4+/CD8+/CD103+ immu-
nophenotype was reported [17]. Because a CD4+/CD8+
phenotype is more consistent with immature T cells, the
possibility of a bona fide lymphoblastic lymphoma could
not be excluded in that case. Based on the CD3+/CD4+/
CD8−/Granzyme B− immunophenotype, we assume that
our case is more likely CD103−, and thus may fall into this
subtype of primary GTCL. When this subtype occurred
primarily in the stomach, it resembled nodal T cell
lymphomas as they displayed a CD4 phenotype and lacked
cytotoxic granules [5]. However, because the stomach does
not normally have organized lymphoid tissue [24], the
lymphoma cells might have either migrated from the lymph
nodes or arisen from the CD4+ T cells of MALT, as a result
of chronic inflammation [18]. With immunohistochemistry,
we identified many CD4+/CD8− T cells in the MALT of H.
pylori chronic gastritis and the current lymphoma. We thus
speculate that it is possible that peripheral T cell lymphoma
could originate from the T cells of MALT. Because the
current patient did not show evidence of H. pylori infection,
these T cells may have migrated to the stomach in response
to other unidentified stimulation.
a 
b 
Fig. 4 Morphologic changes of the primary GTCL after the radiation
therapy (H&E, × 400 amplification). a The large neoplastic cells
show hyperchromatic giant nuclei in a background of acute inflam-
mation (at 2 1/2 weeks after radiation); b rare large atypical T cells are
present (arrow) in a background of reactive lymphoplasmacytosis (at
3 months after radiation)
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cell subtype (CD4−/CD8+/CD103+) with expression of
TIA-1 and Granzyme B [13–17]. Rare CD4−/CD8−/CD56+
cases were also included in this subtype [18]. Because the
immunophenotype of these lymphoma cells resembled
CD103+ IEL of the small and large intestines [24], it was
suggested that these lymphoma cells originated from the
IEL [17]. The IEL also give rise to the enteropathy-
associated T cell lymphoma (EATL), an aggressive intesti-
nal malignancy frequently associated with celiac disease
[25]. Because of this, CD103 is considered specific for
EATL. However, gastric lymphomas in HTLV-1 patients
were also frequently CD103+, questioning the specificity of
CD103 for EATL [18]. A possible link between EATL and
Table 2 Classification of primary GTCL






Granzyme B − +/−
TIA-1 −/+ +
TIA-1: T cell intracellular antigen 1
Table 1 Summary of reported cases of primary GTCL
Case
a Age/sex Diagnosis Immunophenotype Reference
1 66/F HG primary GTCL CD2+/CD4+/CD8−/CD30− [10]
2 18/M HG primary GTCL CD2+/CD4+/CD8− [10]
3 46/M Primary GTCL, large cell CD3+/CD4+/CD8−/CD30+/ALK-1−/TIA-1+/CD103−/EBER(−)[ 11]
4 62/M Primary GTCL, large cell CD3+/CD4+/CD8−/CD30−/CD56−/TIA-1−/EBER(−)[ 11]
5 49/F Primary GTCL, large cell CD3+/CD4−/CD8+/CD30+/ALK-1−/TIA-1+/EBER(+) [11]
6 47/F Primary GTCL, large cell CD3+/CD4−/CD8−/CD30−/CD56−/TIA-1+/EBER(−)[ 11]
7 75/M Primary GTCL, mixed
small and large
CD3+/CD4+/CD8− [12]
8 24/M Primary GTCL, NK-like CD3+/CD8±/CD56+/TCR+/H. pylori(+) [13]
9 73/F Primary GTCL, cytotoxic CD3+/CD4±/CD8+/CD30−/CD56±/TIA-1+/Granzyme B+/Perforin+/
HTLV-1(−)/H. pylori(−)/EBV(−)
[14]
10 47/F Primary GTCL, cytotoxic CD3+/CD4−/CD8−/CD30−/TIA-1+/Granzyme B+/EBER(−)[ 15]
11 56/M Primary GTCL, pleomorphic CD3+/CD4−/CD8−/TIA-1+/CD30+/Granzyme B+/Perforin+/
CD103+/H. pylori(−)/EBER(−)
[16]
12 41/M Primary GTCL, pleomorphic CD3+/CD4+/CD8−/TIA-1−/CD30+/Granzyme B−/H. pylori(−)[ 16]















16 45/M Primary GTCL, mixed cell CD3+/CD4+/CD8−/CD30+/CD56−/ALK-1−/TIA-1−/EBER(−)[ 11]
17 66/M Primary GTCL, mixed cell CD3+/CD4+/CD8−/CD30+/CD56−/TIA-1+/EBER(−)[ 11]
18 64/M Primary GTCL, mixed cell CD3+/CD4+/CD8−/CD30+/ALK-1−/TIA-1+/CD103−/EBER(+) [11]
19 70/M Primary GTCL, mixed cell CD3+/CD4−/CD8+/CD30−/CD56−/ALK−/TIA-1−/EBER(−)[ 11]
20 62/F Primary GTCL, mixed cell CD3+/CD4−/CD8−/CD30+/ALK-1−/TIA-1−/CD103−/EBER(−)[ 11]
21 51/M Primary GTCL, medium-sized CD3+/CD4+/CD8−/CD30+/CD56−/ALK-1−/TIA-1+/EBER(−)[ 11]
22 44/M Primary GTCL, medium-sized CD3+/CD4−/CD30−/CD56−/TIA-1−/EBER(−)[ 11]
23 76/F Primary GTCL, medium-sized CD3+/CD4+/CD8+/CD30−/CD56−/CD103+/TIA-1+/
Perforin−/Granzyme B−/EBV(−)/HTLV(−)
[17]
24 52/M Primary GTCL, small- and
medium-sized
CD3+/CD4+/CD8− [12]
25 73/M Primary GTCL, small cell CD3+/CD45RO+/HTLV-1(−)[ 19]
26 51/M Primary GTCL, small cell CD3+/CD4+/CD8−/CD30−/CD56−/HTLV-1(−)/
H. pylori(−)/EBER(−)
This case
ALK-1: anaplastic lymphoma kinase 1, EBV: Epstein–Barr virus, EBER: EBVearly RNA, GTCL: gastric Tcell lymphoma, HG: high grade, HTLV-
1: human T cell leukemia virus type 1, TCR: T cell receptor, TIA-1: T cell intracellular antigen 1
aOnly the HTLV-1(−) cases with detailed immunohistochemical studies were included in this table.
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indicated that H. pylori could be the cause of some EATL
[18]. Even though EATL can be of small cell type and can
occur primarily in the stomach, our current case neither
showed an immunophenotype of the IEL nor had a history
of celiac disease. In addition, our studies showed no
evidence of EBV, HTLV-1, or H. pylori infection in the
patient. Although the EATL arising from the small intestine
IEL were usually associated with a poor prognosis, there
was at least one report that a primary GTCL regressed after
the eradication of H. pylori and the patient remained in
remission for over 2 years [13].
With very few cases, the etiology of primary GTCL is
unknown. An association was found between primary GTCL
and various infections, such as HTLV-1 [21, 28], H. pylori
[13, 18], or EBV [17, 26, 29] infections. In a study of 233
gastric lymphomas, Nakamura et al. reported that 73% (11/
15) of the GTCL had coexisting H. pylori infection [30],
supporting a possible role of H. pylori in the development of
GTCL. We have sought for evidence of infections in our
patient. However, the patient was seronegative for HTLV-1.
Immunohistochemical stain for H. pylori a n di ns i t u
hybridization for EBV were both negative. The pathogen
that led to the development of the current T cell lymphoma,
if it exists, remains to be determined.
The majority of the reported GTCL have large cell
morphology. This may suggest that the small cell type
GTCL is rare or that they rapidly undergo large cell
transformation before detection. As reported in B cell
MALT lymphomas [7], it is also possible that peripheral T
cell lymphoma arising from gastric MALT may also have
small cell and large cell variants. When the small cell
variants transform into large cell variants, they may be
associated with CD30 expression [11]. Future cytogenetic
and molecular studies may help to further define these rare
lymphomas.
In summary, we have described a rare case of GTCL and
reviewed all the previously reported GTCL in the English
literature. Small cell GTCL are extremely rare. However,
because small cell GTCL can morphologically mimic
extranodal marginal zone B cell lymphoma, we should
recognize this entity in the differential diagnosis when
encountering atypical lymphoid infiltrates with lymphoepi-
thelial lesions in the stomach. Our report also raises a
question: whether a T cell lymphoma could ever arise from
the gastric MALT as well?
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